CVAS-an interesting california-based biotech company here Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVAS-an interesting california-based biotech company here

CVAS 0.000400

0.0%

Oct 7 9:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (115)	3/5/2003 5:58:03 PM
From: Miljenko Zuanic	Read Replies (1) of 126

<<Lampert 100% right IMO.>> Lampert is thinking only about his pocket. He played dirty early with CVAS and he will play dirty again. REW is a joke. He was living good life at SD and now it comes to the end. He is looking for exit (as Lampert is), and DNDN was probably best offer, if they did try to negotiate with other bios. MLNM is better choice, but MLNM is not in position to make major move at the moment. CVAS is afraid that NAPc2 will fail and they will have nothing than ~$50M cash to offer in few months. I do not know what is Provenge chance for success? Maybe better than NAPc2, maybe worse? Miljenko PS: CVAS chemistry is zero, protein biology may be bit better, but so far they did not generated anything.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next